Celldex Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CLDX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -54.37 M-44.01 M-48.63 M-63.94 M-65.59 M -222.16 M Cash from investing activities 42.95 M49.85 M60.85 M55.42 M72.12 M 238.24 M Cash from financing activities 202 K63 K774 K1.35 M327 K 2.51 M Free cash flow -54.37 M-44.01 M-48.63 M-63.94 M-65.59 M -222.16 M

News

QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

Innoviva (INVA) Tops Q1 Earnings Estimates

Wall Street Analysts See a 76.42% Upside in Celldex (CLDX): Can the Stock Really Move This High?

Celldex Therapeutics stock hits 52-week high at $31.36

Celldex presents phase 2 data for chronic urticaria treatment

Celldex Therapeutics Stock Earns 88 RS Rating

Celldex Therapeutics earnings missed by $0.21, revenue fell short of estimates

Celldex Therapeutics stock hits 52-week high at 30.66 USD

Stifel reiterates Celldex Therapeutics stock rating on trial progress

Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule

Celldex stock rating reiterated as Overweight by Cantor Fitzgerald